Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice

Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice

10.18632/oncotarget.442

Saved in:

Bibliographic Details
Main Authors:	Guo, Ke, Tang, Jing Ping, Jie, Li, Al-Aidaroos, Abdul Qader O, Hong, Cheng William, Tan, Cheng Peow Bobby, Park, Jung Eun, Varghese, Leyon, Feng, Zhiwei, Zhou, Jianbiao, Chng, Wee Joo, Zeng, Qi
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Language:	English
Published:	IMPACT JOURNALS LLC 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Cell Biology PRL-3 monoclonal antibody PRL-3 mouse/human chimeric antibody antibody therapy intracellular oncoprotein MONOCLONAL-ANTIBODIES TYROSINE-PHOSPHATASE METASTASIS MARKERS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/203816
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.18632/oncotarget.442